Late-Stage Stumble for Cosentyx Sets Novartis Back in Autoimmune Condition
Novartis is falling farther behind AbbVie, which expanded its JAK inhibitor Rinvoq into giant cell arteritis in April.
Late-Stage Stumble for Cosentyx Sets Novartis Back in Autoimmune Condition Read More »
